InterventionsHumans
SAT-669 Impact of GLP-1 agonist in patients with heart failure and dyslipidemia affected by Metabolic Dysfunction-Associated Steatotic Liver Disease: A prospective case control study
ENDO 2025 Abstract
The paper
Mateo FR, Ajenaghughrure G, Polanco G et al.
ENDO 2025 Abstract · 22 Oct 2025 · CC BY-NC-ND
Presented at ENDO 2025
